Skip to main content
. 2021 Oct 28;35(12):e24078. doi: 10.1002/jcla.24078

FIGURE 5.

FIGURE 5

Clinical correlations between miR125a5p and its targets in gastric cancers (GCs). (A) The expression of miR125a5p was detected in 65 GC tissues and noncancerous gastric tissues. (B) Expression levels of miR125a5p in GCs of different stages. (C) Correlations between miR125a5p levels and the expression levels of putative targets in GCs were demonstrated. NC, noncancerous gastric tissues; ***p < 0.001 compared with NC, stage I GCs, and stage II GCs